<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182023000200741</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v52n2.110734</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Bone therapy through drug delivery of chelated [bisphosphonate-metal ions] adsorbed on the surface of carbon nanotubes]]></article-title>
<article-title xml:lang="es"><![CDATA[Terapia ósea a través de la administración de fármacos tipo quelatos [iones bisfosfonato-metal] adsorbidos en la superficie de nanotubos de carbono]]></article-title>
<article-title xml:lang="pt"><![CDATA[Terapia óssea por meio de administração do quelatos [íons bifosfonato-metal] adsorvidos na superfície de nanotubos de carbono]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mollaamin]]></surname>
<given-names><![CDATA[Fatemeh]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Monajjemi]]></surname>
<given-names><![CDATA[Majid]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Kastamonu University  ]]></institution>
<addr-line><![CDATA[Kastamonu ]]></addr-line>
<country>Turkey</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Islamic Azad University  ]]></institution>
<addr-line><![CDATA[Tehran ]]></addr-line>
<country>Iran</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2023</year>
</pub-date>
<volume>52</volume>
<numero>2</numero>
<fpage>741</fpage>
<lpage>765</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182023000200741&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182023000200741&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182023000200741&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[SUMMARY  Aim To investigate asingle-walled carbon nanotube (SWCNT) joint to bisphosphonate agents of 5AEL, 5AFX, 4QPF, 3DYG, 2F92, 2I19 chelated to metal cations of Mg2+, Ca2+, Sr2+ due to the direct electron transfer principle which has been studied by density functional theory methods.  Method It has been accomplished the B3LYP/6-311+G(d,p)/LANL2DZ to estimate the susceptibility of SWCNT for adsorbing 5AEL, 5AFX, 4QPF, 3DYG, 2F92, 2I19 chelated to metal cations of Mg2+, Ca2+, Sr2+ through nuclear magnetic resonance and thermodynamic parameters.  Results The data explained that the feasibility of using SWCNT and bisphosphonate agents becomes the norm in metal chelating of delivery system, which has been selected through several bisphosphonate agents of 5AEL, 5AFX, 4QPF, 3DYG, 2F92, and 2I19 using DFT method due to physico-chemical properties of NMR and IR methodologies.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo investigar la unión de nanotubos de carbono de pared simple (SWCNT) con agentes bisfosfonatos de 5AEL, 5AFX, 4QPF, 3DYG, 2F92, 2I19 quelados con cationes metálicos de Mg2+, Ca2+, Sr2+ debido al principio de transferencia directa de electrones que tiene ha sido estudiado por métodos de la teoría funcional de la densidad.  Método se ha realizado el B3LYP/6-311+G(d,p)/LANL2DZ para estimar la susceptibilidad de SWCNT para adsorber 5AEL, 5AFX, 4QPF, 3DYG, 2F92, 2I19 quelados a cationes metálicos de Mg2+, Ca2+, Sr2+ mediante resonancia magnética nuclear y parámetros termodinámicos.  Resultados los datos explicaron que la viabilidad de usar SWCNT y agentes bisfosfonatos se convierte en la norma en el sistema de entrega de quelación de metales, que ha sido seleccionado a través de varios agentes bisfosfonatos de 5AEL, 5AFX, 4QPF, 3DYG, 2F92 y 2I19 usando el método DFT debido a propiedades fisicoquímicas de los métodos de RMN e IR.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Objetivo investigar os nanotubos de carbono de parede simples (SWCNT) unidos a agentes bifosfonatos de 5AEL, 5AFX, 4QPF, 3DYG, 2F92, 2I19 quelatados a cátions metálicos de Mg2+, Ca2+, Sr2+ devido ao princípio de transferência direta de elétrons que tem tem sido estudado por métodos da teoria do funcional da densidade.  Metodo foi realizado o B3LYP/6-311+G(d,p)/LANL2DZ para estimar a suscetibilidade do SWCNT para adsorver 5AEL, 5AFX, 4QPF, 3DYG, 2F92, 2I19 quelatados a cátions metálicos de Mg2+, Ca2+, Sr2+ por ressonância magnética nuclear e parâmetros termodinâmicos.  Resultados os dados explicaram que a viabilidade do uso de agentes SWCNT e bisfosfonatos se torna a norma no sistema de entrega de quelante de metal, que foi selecionado por meio de vários agentes bisfosfonatos de 5AEL, 5AFX, 4QPF, 3DYG, 2F92 e 2I19 usando o método DFT devido a propriedades físico-químicas de metodologias de RMN e IV.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[(5,5) armchair SWCNT]]></kwd>
<kwd lng="en"><![CDATA[protein-bisphosphonate]]></kwd>
<kwd lng="en"><![CDATA[metal chelating]]></kwd>
<kwd lng="es"><![CDATA[(5.5) sillón SWCNT]]></kwd>
<kwd lng="es"><![CDATA[proteína-bifosfonato]]></kwd>
<kwd lng="es"><![CDATA[quelación de metales]]></kwd>
<kwd lng="pt"><![CDATA[(5,5) poltrona SWCNT]]></kwd>
<kwd lng="pt"><![CDATA[proteína-bifosfonato]]></kwd>
<kwd lng="pt"><![CDATA[quelantes de metais]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>[1]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kistler-Fischbacher]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Weeks]]></surname>
<given-names><![CDATA[B.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Beck]]></surname>
<given-names><![CDATA[B.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of exercise intensity on bone in postmenopausal women (part 2): A meta-analysis]]></article-title>
<source><![CDATA[Bone]]></source>
<year>2021</year>
<volume>143</volume>
<page-range>115697</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>[2]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Åkesson]]></surname>
<given-names><![CDATA[K.E.]]></given-names>
</name>
<name>
<surname><![CDATA[McGuigan]]></surname>
<given-names><![CDATA[F.E.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Closing the osteoporosis care gap]]></article-title>
<source><![CDATA[Curr. Osteoporos. Rep.]]></source>
<year>2021</year>
<volume>19</volume>
<page-range>58-65</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>[3]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tiwari]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Tiwari]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Sriwastawa]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhati]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Pandey]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Pandey]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Banerjee]]></surname>
<given-names><![CDATA[S.K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug delivery systems: An updated review]]></article-title>
<source><![CDATA[Int. J. Pharm. Investig.]]></source>
<year>2012</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>2-11</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>[4]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Zeng]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Shan]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Tong]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microneedle patches as drug and vaccine delivery platform]]></article-title>
<source><![CDATA[Curr. Med. Chem.]]></source>
<year>2017</year>
<volume>24</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>2413-22</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>[5]</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tekade]]></surname>
<given-names><![CDATA[R.K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Basic fundamentals of drug delivery]]></source>
<year>2018</year>
<publisher-name><![CDATA[Academic Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>[6]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[T.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug delivery systems: Entering the mainstream]]></article-title>
<source><![CDATA[Science]]></source>
<year>2004</year>
<volume>303</volume>
<numero>5665</numero>
<issue>5665</issue>
<page-range>1818-22</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>[7]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[A.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Biswas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Shukla]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Maiti]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles]]></article-title>
<source><![CDATA[Sig. Transduct. Target. Ther.]]></source>
<year>2019</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>[8]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohsin]]></surname>
<given-names><![CDATA[S.M.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein]]></surname>
<given-names><![CDATA[M.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Sarijo]]></surname>
<given-names><![CDATA[S.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Fakurazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Arulselvan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Taufiq-Yap]]></surname>
<given-names><![CDATA[Y.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characterisation and cytotoxicity assessment of UV absorbers-intercalated zinc/aluminium-layered double hydroxides on dermal fibroblast cells]]></article-title>
<source><![CDATA[Science of Advanced Materials]]></source>
<year>2014</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>648-58</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>[9]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saifullah]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein]]></surname>
<given-names><![CDATA[M.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein-Al-Ali]]></surname>
<given-names><![CDATA[S.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Arulselvan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Fakurazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocomposites]]></article-title>
<source><![CDATA[Drug Des. Devel. Ther.]]></source>
<year>2013</year>
<volume>7</volume>
<page-range>1365-75</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>[10]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barahuie]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein]]></surname>
<given-names><![CDATA[M.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein-Al-Ali]]></surname>
<given-names><![CDATA[S.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Arulselvan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Fakurazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Zainal]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preparation and controlled-release studies of a protocatechuic acid-magnesium/aluminumlayered double hydroxide nanocomposite]]></article-title>
<source><![CDATA[Int. J. Nanomedicine]]></source>
<year>2013</year>
<volume>8</volume>
<page-range>1975-87</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>[11]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kura]]></surname>
<given-names><![CDATA[A.U.]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[S.H.H.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein]]></surname>
<given-names><![CDATA[M.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Fakurazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Arulselvan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent]]></article-title>
<source><![CDATA[Int. J. Nanomedicine]]></source>
<year>2013</year>
<volume>8</volume>
<page-range>1103-10</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>[12]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohsin]]></surname>
<given-names><![CDATA[S.M.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein]]></surname>
<given-names><![CDATA[M.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Sarijo]]></surname>
<given-names><![CDATA[S.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Fakurazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Arulselvan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Hin]]></surname>
<given-names><![CDATA[T.Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Synthesis of (cinnamate-zinc layered hydroxide) intercalation compound for sunscreen application]]></article-title>
<source><![CDATA[Chem. Cent. J.]]></source>
<year>2013</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>[13]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohsin]]></surname>
<given-names><![CDATA[S.M.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Hussein]]></surname>
<given-names><![CDATA[M.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Sarijo]]></surname>
<given-names><![CDATA[S.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Fakurazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Arulselvan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Taufiq-Yap]]></surname>
<given-names><![CDATA[Y.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimization of UV absorptivity of layered double hydroxide by intercalating organic UV-absorbent molecules]]></article-title>
<source><![CDATA[J. Biomed. Nanotechnol.]]></source>
<year>2014</year>
<volume>10</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1490-500</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>[14]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Deng]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs]]></article-title>
<source><![CDATA[Eur. J. Pharm. Sci.]]></source>
<year>2013</year>
<volume>48</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>64-71</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>[15]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghaffarian]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhowmick]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Muro]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1]]></article-title>
<source><![CDATA[J. Control. Release]]></source>
<year>2012</year>
<volume>163</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-33</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>[16]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Xue]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Keefe]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multifunctional and degradable zwitterionic nanogels for targeted delivery, enhanced MR imaging, reduction-sensitive drug release, and renal clearance]]></article-title>
<source><![CDATA[Biomaterials]]></source>
<year>2011</year>
<volume>32</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>4604-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>[17]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bethune]]></surname>
<given-names><![CDATA[D.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kiang]]></surname>
<given-names><![CDATA[C.H.]]></given-names>
</name>
<name>
<surname><![CDATA[de Vries]]></surname>
<given-names><![CDATA[M.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cobalt-catalysed growth of carbon nanotubes with single-atomic-layer walls]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1993</year>
<volume>363</volume>
<numero>6430</numero>
<issue>6430</issue>
<page-range>605-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>[18]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iijima]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ichihashi]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Single-shell carbon nanotubes of 1-nm diameter]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1993</year>
<volume>363</volume>
<numero>6430</numero>
<issue>6430</issue>
<page-range>603-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>[19]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dai]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carbon nanotubes: opportunities and challenges]]></article-title>
<source><![CDATA[Surface Science]]></source>
<year>2002</year>
<volume>500</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>218-41</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>[20]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abi]]></surname>
<given-names><![CDATA[T.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Karmakar]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Taraphder]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proton affinity of polar amino acid sidechain analogues anchored to the outer wall of single walled carbon nanotubes]]></article-title>
<source><![CDATA[Comput. Theor. Chem.]]></source>
<year>2013</year>
<volume>1010</volume>
<page-range>53-66</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>[21]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Ji]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enzymes immobilized on carbon nanotubes]]></article-title>
<source><![CDATA[Biotechnol. Adv.]]></source>
<year>2011</year>
<volume>29</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>889-95</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>[22]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Q.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaneko]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Hatakeyama]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characterization of pulse-driven gas-liquid interfacial discharge plasmas and application to synthesis of gold nanoparticle-DNA encapsulated carbon nanotubes]]></article-title>
<source><![CDATA[Curr. Appl. Phys.]]></source>
<year>2011</year>
<volume>11</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>S63-6</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>[23]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mbese]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Aderibigbe]]></surname>
<given-names><![CDATA[B.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bisphosphonate-based conjugates and derivatives as potential therapeutic agents in osteoporosis, bone cancer and metastatic bone cancer]]></article-title>
<source><![CDATA[Int. J. Mol. Sci.]]></source>
<year>2021</year>
<volume>22</volume>
<page-range>6869</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>[24]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rauner]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Taipaleenmäki]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Tsourdi]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Winter]]></surname>
<given-names><![CDATA[E.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application]]></article-title>
<source><![CDATA[J. Clin. Med.]]></source>
<year>2021</year>
<volume>10</volume>
<page-range>787</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>[25]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Geiger]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Kammerlander]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Höfer]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Volland]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Trinemeier]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Henschelchen]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Friess]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Böcker]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Sundmacher]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<collab>FLS-CARE study group</collab>
<article-title xml:lang=""><![CDATA[Implementation of an integrated care programme to avoid fragility fractures of the hip in older adults in 18 Bavarian hospitals---study protocol for the cluster-randomised controlled fracture liaison service FLS-CARE]]></article-title>
<source><![CDATA[BMC Geriatr.]]></source>
<year>2021</year>
<volume>21</volume>
<page-range>43</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>[26]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hayes]]></surname>
<given-names><![CDATA[K.N.]]></given-names>
</name>
<name>
<surname><![CDATA[He]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[K.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Juurlink]]></surname>
<given-names><![CDATA[D.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Cadarette]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: Novel rolling window approach and patterns of use]]></article-title>
<source><![CDATA[Osteoporos. Int.]]></source>
<year>2021</year>
<volume>32</volume>
<page-range>1413-20</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>[27]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sølling]]></surname>
<given-names><![CDATA[A.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Christensen]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Darvalics]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Harsløf]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Thomsen]]></surname>
<given-names><![CDATA[R.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Langdahl]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fracture rates in patients discontinuing alendronate treatment in real Life: A population-based cohort study]]></article-title>
<source><![CDATA[Osteoporos. Int.]]></source>
<year>2021</year>
<volume>32</volume>
<page-range>1103-15</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>[28]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J.-W.]]></given-names>
</name>
<name>
<surname><![CDATA[Yee]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Oh]]></surname>
<given-names><![CDATA[S.-H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S.-H.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S.-J.]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[J.-E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gwak]]></surname>
<given-names><![CDATA[H.-S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Machine learning approaches for predicting bisphosphonate-related osteonecrosis in women with osteoporosis using VEGFA gene polymorphisms]]></article-title>
<source><![CDATA[Journal of Personalized Medicine]]></source>
<year>2021</year>
<volume>11</volume>
<page-range>541</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>[29]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Langdahl]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overview of treatment approaches to osteoporosis]]></article-title>
<source><![CDATA[Br. J. Pharmacol.]]></source>
<year>2021</year>
<volume>178</volume>
<page-range>1891-906</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>[30]</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frisch]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Trucks]]></surname>
<given-names><![CDATA[G.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Schlegel]]></surname>
<given-names><![CDATA[H.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Scuseria]]></surname>
<given-names><![CDATA[G.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Robb]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cheeseman]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Scalmani]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Gaussian]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Wallingford CT. ]]></publisher-loc>
<publisher-name><![CDATA[Gaussian, Inc.]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<label>[31]</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koch]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Holthausen]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
</person-group>
<source><![CDATA[A chemist's guide to density functional theory]]></source>
<year>2000</year>
<edition>2nd</edition>
<page-range>3-64, 93-104</page-range><publisher-loc><![CDATA[Weinheim, Germany ]]></publisher-loc>
<publisher-name><![CDATA[Wiley-VCH]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>[32]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becke]]></surname>
<given-names><![CDATA[A.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Density&#8208;functional thermochemistry. III. The role of exact exchange]]></article-title>
<source><![CDATA[J. Chem. Phys.]]></source>
<year>1993</year>
<volume>98</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>5648-52</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>[33]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becke]]></surname>
<given-names><![CDATA[A.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Density-functional exchange-energy approximation with correct asymptotic behavior]]></article-title>
<source><![CDATA[Phys. Rev. A]]></source>
<year>1988</year>
<volume>38</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>3098-100</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>[34]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Parr]]></surname>
<given-names><![CDATA[R.G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density]]></article-title>
<source><![CDATA[Phys. Rev. B, Condens. Matter.]]></source>
<year>1988</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>785-9</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>[35]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stephens]]></surname>
<given-names><![CDATA[P.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Devlin]]></surname>
<given-names><![CDATA[F.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Chabalowski]]></surname>
<given-names><![CDATA[C.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Frisch]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields]]></article-title>
<source><![CDATA[J. Phys. Chem.]]></source>
<year>1994</year>
<volume>98</volume>
<numero>45</numero>
<issue>45</issue>
<page-range>11623-7</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>[36]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cramer]]></surname>
<given-names><![CDATA[C.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Truhlar]]></surname>
<given-names><![CDATA[D.G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PM3-SM3: A general parameterization for including aqueous solvation effects in the PM3 molecular orbital model]]></article-title>
<source><![CDATA[J. Comput. Chem.]]></source>
<year>1992</year>
<volume>13</volume>
<page-range>1089-97</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>[37]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liotard]]></surname>
<given-names><![CDATA[D.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hawkins]]></surname>
<given-names><![CDATA[G.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Lynch]]></surname>
<given-names><![CDATA[G.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Cramer]]></surname>
<given-names><![CDATA[C.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Truhlar]]></surname>
<given-names><![CDATA[D.G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improved methods for semiempirical solvation models]]></article-title>
<source><![CDATA[J. Comput. Chem.]]></source>
<year>1995</year>
<volume>16</volume>
<page-range>422-40</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>[38]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chambers]]></surname>
<given-names><![CDATA[C.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hawkins]]></surname>
<given-names><![CDATA[G.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Cramer]]></surname>
<given-names><![CDATA[C.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Truhlar]]></surname>
<given-names><![CDATA[D.G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Model for aqueous solvation based on class IV atomic charges and first solvation shell effects]]></article-title>
<source><![CDATA[J. Phys. Chem.]]></source>
<year>1996</year>
<volume>100</volume>
<numero>40</numero>
<issue>40</issue>
<page-range>16385-98</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>[39]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giesen]]></surname>
<given-names><![CDATA[D.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[M.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Cramer]]></surname>
<given-names><![CDATA[C.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Truhlar]]></surname>
<given-names><![CDATA[D.G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A universal organic solvation model]]></article-title>
<source><![CDATA[J. Org. Chem.]]></source>
<year>1996</year>
<volume>61</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>8720-1</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>[40]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Onsager]]></surname>
<given-names><![CDATA[L.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Electric moments of molecules in liquids]]></article-title>
<source><![CDATA[J. Am. Chem. Soc.]]></source>
<year>1936</year>
<volume>58</volume>
<page-range>1486-93</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>[41]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tomasi]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cavity and reaction field: "robust" concepts. Perspective on "Electric moments of molecules in liquids"]]></article-title>
<source><![CDATA[Theor. Chem. Acc.]]></source>
<year>2000</year>
<volume>103</volume>
<page-range>196-9</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>[42]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Pandya]]></surname>
<given-names><![CDATA[V.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ezekiel]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Berghuis]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phosphonate and bisphosphonate inhibitors of farnesyl pyrophosphate synthases: A structure-guided perspective]]></article-title>
<source><![CDATA[Front. Chem.]]></source>
<year>2021</year>
<volume>8</volume>
<page-range>612728</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>[43]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marocco]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Zimatore]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Mocini]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Fornari]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Iolascon]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallotta]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bimonte]]></surname>
<given-names><![CDATA[V.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Baldari]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Lenzi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Migliaccio]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of denosumab therapy following treatment with bisphosphonates in women with osteoporosis: A cohort study]]></article-title>
<source><![CDATA[Int. J. Environ. Res. Public Health]]></source>
<year>2021</year>
<volume>18</volume>
<page-range>1728</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>[44]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Pandya]]></surname>
<given-names><![CDATA[V.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ezekiel]]></surname>
<given-names><![CDATA[S.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Berghuis]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phosphonate and bisphosphonate inhibitors of farnesyl pyrophosphate synthases: A structure-guided perspective]]></article-title>
<source><![CDATA[Front. Chem.]]></source>
<year>2021</year>
<volume>8</volume>
<page-range>612728</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>[45]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adjei-Sowah]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Peng]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Weeks]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Jonason]]></surname>
<given-names><![CDATA[J.H.]]></given-names>
</name>
<name>
<surname><![CDATA[de Mesy-Bentley]]></surname>
<given-names><![CDATA[K.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Masters]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of bisphosphonate-conjugated antibiotics to overcome pharmacodynamic limitations of local therapy: Initial results with carbamate linked sitafloxacin and tedizolid]]></article-title>
<source><![CDATA[Antibiotics]]></source>
<year>2021</year>
<volume>10</volume>
<page-range>732</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>[46]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[RANKL as a therapeutic target of rheumatoid arthritis]]></article-title>
<source><![CDATA[J. Bone Miner. Metab.]]></source>
<year>2021</year>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>106-12</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>[47]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vassaki]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Kotoula]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Turhanen]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Choquesillo-Lazarte]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Demadis]]></surname>
<given-names><![CDATA[K.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calcium and strontium coordination polymers as controlled delivery systems of the anti-osteoporosis drug risedronate and the augmenting effect of solubilizers]]></article-title>
<source><![CDATA[Appl. Sci.]]></source>
<year>2021</year>
<volume>11</volume>
<page-range>11383</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>[48]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rauch]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Hein]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Biedermann]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Eyerich]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Lauffer]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bisphosphonates for the treatment of calcinosis Cutis-A retrospective single-center study]]></article-title>
<source><![CDATA[Biomedicines]]></source>
<year>2021</year>
<volume>9</volume>
<page-range>1698</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>[49]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fry]]></surname>
<given-names><![CDATA[R.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Kwon]]></surname>
<given-names><![CDATA[K.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Komarneni]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kubicki]]></surname>
<given-names><![CDATA[J.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Mueller]]></surname>
<given-names><![CDATA[K.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Solid-state NMR and computational chemistry study of mononucleotides adsorbed to alumina]]></article-title>
<source><![CDATA[Langmuir]]></source>
<year>2006</year>
<volume>22</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>9281-6</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>[50]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sarasia]]></surname>
<given-names><![CDATA[E.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Afsharnezhad]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Honarparvar]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Mollaamin]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Monajjemi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estrogenic active stilbene derivatives as anti-cancer agents: A DFT and QSAR study]]></article-title>
<source><![CDATA[Phys. Chem. Liq.]]></source>
<year>2011</year>
<volume>49</volume>
<page-range>561-71</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>[51]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghalandari]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Monajjemi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mollaamin]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Theoretical investigation of carbon nanotube binding to DNA in view of drug delivery]]></article-title>
<source><![CDATA[J. Comput. Theor. Nanosci.]]></source>
<year>2011</year>
<volume>8</volume>
<page-range>1212-9</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>[52]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monajjemi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Farahani]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Mollaamin]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thermodynamic study of solvent effects on nanostructures: Phosphatidylserine and phosphatidylinositol membranes]]></article-title>
<source><![CDATA[Phys. Chem. Liq.]]></source>
<year>2012</year>
<volume>50</volume>
<page-range>161-72</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>[53]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khaleghian]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Zahmatkesh]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mollaamin]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Monajjemi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigation of solvent effects on armchair single-walled carbon nanotubes: A QM/MD study]]></article-title>
<source><![CDATA[Fuller. Nanotub. Carbon Nanostructures]]></source>
<year>2011</year>
<volume>19</volume>
<page-range>251-61</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
